Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Primiano Christopher Brett
EVP, CBO, GC & Secretary at Karyopharm Therapeutics. Filing since 13 May 2014.
CIK 0001603510
Company
Date
Role
Action
Shares
Amount
Of holding
KPTI
Karyopharm Therapeutics Inc.
1 Dec 2020
EVP, CBO, GC & Secretary
Sold, plan not stated
137,061
$2.40M
96.8%
KPTI
Karyopharm Therapeutics Inc.
2 Nov 2020
EVP, CBO, GC & Secretary
Sold, plan not stated
772
$11.52K
14.6%
KPTI
Karyopharm Therapeutics Inc.
13 Oct 2020
EVP, CBO, GC & Secretary
Sold, plan not stated
39,271
$661.97K
89.4%
KPTI
Karyopharm Therapeutics Inc.
8 Sep 2020
EVP, CBO, GC & Secretary
Sold, plan not stated
10,054
$150.61K
68.4%
KPTI
Karyopharm Therapeutics Inc.
7 May 2020
EVP, CBO, GC & Secretary
Sold, plan not stated
9,660
$190.63K
67.5%
KPTI
Karyopharm Therapeutics Inc.
2 Mar 2020
EVP, CBO, GC & Secretary
Sold, plan not stated
26,500
$672.28K
71.9%
KPTI
Karyopharm Therapeutics Inc.
19 Feb 2020
EVP, CBO, GC & Secretary
Sold, plan not stated
2,961
$48.80K
22.2%
KPTI
Karyopharm Therapeutics Inc.
27 Dec 2019
EVP, CBO, GC & Secretary
Sold, plan not stated
5,000
$100.00K
57.8%
KPTI
Karyopharm Therapeutics Inc.
6 Dec 2019
EVP, CBO, GC & Secretary
Sold, plan not stated
13,000
$226.91K
78.1%
KPTI
Karyopharm Therapeutics Inc.
10 Sep 2018
EVP, CBO, GC & Secretary
Sold, plan not stated
10,000
$189.05K
77.6%
KPTI
Karyopharm Therapeutics Inc.
10 May 2018
EVP, CBO, GC & Secretary
Sold, plan not stated
2,000
$36.02K
41.0%
KPTI
Karyopharm Therapeutics Inc.
5 Mar 2018
EVP, CBO, GC & Secretary
Sold, plan not stated
2,500
$40.08K
33.9%
KPTI
Karyopharm Therapeutics Inc.
16 Feb 2018
EVP, CBO, GC & Secretary
Sold, plan not stated
1,486
$22.30K
16.8%
KPTI
Karyopharm Therapeutics Inc.
15 Feb 2018
EVP, CBO, GC & Secretary
Sold, plan not stated
1,014
$15.23K
10.3%
KPTI
Karyopharm Therapeutics Inc.
7 Feb 2018
EVP, CBO, GC & Secretary
Sold, plan not stated
1,500
$19.50K
13.2%
KPTI
Karyopharm Therapeutics Inc.
12 Dec 2017
SVP, OPS, BUS DEV, GC & SEC
Sold, plan not stated
17,000
$168.62K
59.9%
KPTI
Karyopharm Therapeutics Inc.
11 Dec 2017
SVP, OPS, BUS DEV, GC & SEC
Sold, plan not stated
10,042
$109.26K
46.9%
KPTI
Karyopharm Therapeutics Inc.
7 Nov 2017
SVP, OPS, BUS DEV, GC & SEC
Sold, plan not stated
4,958
$55.76K
18.8%
KPTI
Karyopharm Therapeutics Inc.
2 Oct 2017
SVP, OPS, BUS DEV, GC & SEC
Sold, plan not stated
1,500
$18.00K
11.6%
KPTI
Karyopharm Therapeutics Inc.
15 Sep 2017
SVP, OPS, BUS DEV, GC & SEC
Sold, plan not stated
2,000
$22.00K
13.4%
KPTI
Karyopharm Therapeutics Inc.
29 Aug 2017
SVP, OPS, BUS DEV, GC & SEC
Sold, plan not stated
2,195
$21.95K
12.3%
KPTI
Karyopharm Therapeutics Inc.
26 Jun 2017
SVP, OPS, BUS DEV, GC & SEC
Sold, plan not stated
805
$8.07K
5.1%
KPTI
Karyopharm Therapeutics Inc.
9 Nov 2016
SVP,CORP DEV,GEN COUNSEL&SEC.
Sold, plan not stated
4,342
$35.54K
21.5%
KPTI
Karyopharm Therapeutics Inc.
13 May 2014
VP, GEN COUNSEL & SECRETARY
Bought
1,000
$26.75K
opened
24 decisions on file.
